Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 7 pages · Chinese
CABIO Biotech (Wuhan) Co. Ltd. on 6ix
Earlier from CABIO Biotech (Wuhan)
- Announcement on Participating in the SSE STAR Market's 2025 Annual Biological Products Industry Collective Performance Briefing and the Q1 2026 Performance Briefing
- Special Report on Deposit and Actual Use of Raised Funds in 2025
- Announcement on Resignation of Directors
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Implementation Result of Phase II Shares Repurchase and Share Changes
Later from CABIO Biotech (Wuhan)
- Announcement on Voluntary Disclosure of the Approval of Lacto-N-neotetraose
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Notifying Creditors Regarding the Cancellation of Repurchased Shares
- Announcement on Imposition of Other Risk Warnings and Trading Suspension
- Announcement on Implementation of Cancellation of Repurchased Shares and Share Changes
Follow CABIO Biotech (Wuhan) into a list and get an email when it puts out news.
Follow CABIO Biotech (Wuhan)